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Seasonality in the presentation of breast cancer has been claimed in
countries with distinct climatic seasons. Thus in northern latitudes,
the peak of the seasonal variation in Israel occurred in Spring
(Cohen et al, 1983), USA in May (Jacobsen and Janerich, 1977),
while Southampton, England it was in June (Kirkham et al, 1985).
In contrast, Galea and Blamey (1991) suggest in Nottingham,
England there is ‘no difference in frequency of tumour detection’ –
here May to August compared to September to April. On the other
hand peaks for those tumours self-detected and requiring surgery
occurred in Spring and late Autumn in the USA (Ross et al, 1997)
with a similar pattern in Bulgaria (Dimitrov et al, 1998). In southern
latitudes the peak of initial detection of breast cancer in Auckland,
New Zealand occurred in December (Holdaway et al, 1990). 
It has been suggested that the peak presentation may vary with
patient characteristics. Thus Kirkham et al (1985) noted that
the seasonality is more pronounced in premenopausal than post-
menopausal women who peaked 3 months earlier in March. They
also suggested that the small tumours (<3 cm diameter) were
diagnosed 1 to 2 months earlier than the larger ones. 
However, in none of these studies has the possibility been
quantified that the seasonal pattern observed is an artifact of the
confounding influence of referral patterns. 
Singapore is a small island and this, as well as the health care
system itself, facilitates open access to care. The 3.7 million popu-
lation comprises peoples whose origins are mainly Chinese (78%),
Malay (14%) or Indian (7%) (Lau, 1993). Being equatorial
(latitude 1˚ north), the tropical climate has a relatively unchanging
pattern over the year with daily temperatures ranging from 24 to
32˚C. As previous studies have all been conducted in countries
with distinct weather patterns and with lower overall health
care delivery system performance (WHO, 2000), evidence from
Singapore may be particularly useful in examining the influence of
any seasonal variation in breast cancer. 
The Singapore Breast Cancer Registry identified all permanent
residents of Singapore with malignant breast carcinoma from
January 1995 to December 1998 and the corresponding medical
and histology records were collected and reviewed. The date of
diagnosis was taken as the day of surgery or when the malignancy
was either clinically or histologically confirmed. These would
usually be some days after the date of first presentation. 
In addition, ethnicity (Chinese, Malay, Indian or others), date of
birth, menstrual, oestrogen and progesterone receptor (ER, PR)
status; tumour size and stage were recorded. Menopausal status
was considered to be uncertain if patients had bilateral oophorec-
tomy. 
Data from each calendar year is standardized to 12 months of
equal duration and the date of peak diagnosis is identified using
the methods described in Machin and Chong (1998). The associ-
ated statistical significance was tested by Mardia c2 statistic with
2 degrees of freedom (Mardia, 1972). The bootstrap technique
(Fisher, 1993) was used to obtain a 95% confidence interval (CI)
for the peak date using 1000 bootstrap samples of the same size as
the number of patients under consideration. 
The variation in date of peak diagnosis between different patient
groups was explored using the methods of Fisher and Lee (1992).
They describe how the regression of an angular variable, the day of
diagnosis of breast cancer within the year, on a potential explan-
atory variable such as menopausal or receptor status can be made. 
In total 3219 women were diagnosed with breast cancer over the
4 years. Figure 1 shows the frequency distribution of the date of
diagnosis, presented as a rose diagram on a half monthly basis.
There is no clear cut seasonal pattern although fewer cases are
diagnosed in January and February (close to the Western and
Chinese New Year festivals) and they appeared more numerous
approximately 6 months later over the June to August period. The
estimated peak (Table 1) of August 27 (95% CI July 14 to October
07) is statistically significant (P = 0.015) but of small magnitude
(R = 0.036). 
Table 1 shows the estimated peaks for groups based on patient
and tumour characteristics recorded at presentation. It is clear, for
example, that the peaks within the 4 ethnic groups are far from
strong, and while those for the Chinese and Others coincide in
August, that for the Malays is 3 weeks earlier in July whereas for
the Indians, it is 2 months later in October. Only that for the Indian
women is statistically significant (P = 0.036) but, with R = 0.160,
this is not very marked. 
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There is only a 4-day difference in the peak dates for pre- and
post-menopausal women. The peaks for ER- and PR-negative
women essentially coincide in late August and early September
respectively and both precede the peaks for the positive tumours
by 1 month. These are all statistically significant but of relatively
low magnitude. The close agreement in the results for ER and PR
status arise since the status is the same for each in 78% of the
women for which they are both observed. 
The date of peak diagnosis for the women who have large sized
tumours (³1 cm) is late August in contrast to early December in
those with the small tumours. However, the only statistically
significant peak is for those with the larger tumours (R = 0.049, 
P = 0.002) but again this is of low magnitude. 
Apart from Stage 0 patients who have an estimated peak in early
July, the higher the stage the earlier the peak in diagnosis although
only that for Stage IIA disease at September 25 is statistically
significant (R = 0.061, P = 0.034). 
Table 2 summarizes the associated regression analyses for the
patient and tumour characteristics that are binary in nature.
However, these analyses did not establish any statistically signifi-
cant differences between the corresponding subgroups. For
example, the observed 3-month difference in the peak dates of
diagnosis for the different-sized tumours is not established as
other than due to chance (b = 1.112, 95% CI: – 0.81 to 3.04, 
P = 0.26). 
A clear drawback of this study (and most others in this area) is
the uncertain relationship between date of diagnosis and date of
onset of symptoms of breast cancer. The latter is more likely to be
aetiologically important as the variable delays from first symptom
to presentation and eventual diagnosis may depend on many
factors. In our situation, the delay between onset of symptoms and
presentation is uncertain but that between presentation and dia-
gnosis is not likely to be great. 
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Figure 1 Rose diagram of half-monthly diagnosis of female malignant
breast cancer patients
Table 1 Summaries of seasonal variation by patient and tumour characteristics at presentation for all women 
Number of cases Corresponding  Magnitude  95% CI Mardia c2 P
calendar date of peak, R
All 3219 Aug 27 0.036 Jul 14–Oct 07  8.41 0.015 
Ethnicity 
Chinese 2743 Aug 21 0.031 Jun 21–Oct 10 5.31 0.070 
Malay 307 Jul 30 0.060 Apr 04–Oct 21 2.22 0.33 
Indian 130 Oct 28 0.160 Sep 09–Dec 13 6.65 0.036 
Others 39 Aug 20 0.130 Mar 30–Dec 06 1.31 0.52 
Menopause 
Pre 1557 Aug 19 0.026 May 22–Jan 24 2.10 0.35 
Uncertain 264
Post 1398 Aug 23 0.036 Jun 13–Nov 04 3.59 0.17 
ER 
Negative 1061 Sep 01 0.084 Jul 27–Sep 30 14.86 0.0006 
Not done 732
Positive 1426 Oct 02 0.056 Aug 26–Nov 15 8.98 0.011 
PR 
Negative 1308 Aug 31 0.071 Jul 27–Oct 02 13.07 0.002 
Not done 779 
Positive 1132 Oct 04 0.076 Sep 09–Nov 19 12.96 0.002 
Tumour (cm) 
<1 338 Dec 06 0.030 Jul 16–May 06 0.60 0.74 
³ 1 2572 Aug 30 0.049 Jul 27–Oct 04 12.20 0.002 
Not done 309 
Stage 
0 276 Jul 05 0.036 Feb 10–Dec 08 0.70 0.71 
I 770 Sep 12 0.042 Jun 13–Dec 11 2.68 0.26 
IIA 922 Sep 25 0.061 Aug 09–Nov 15 6.76 0.034 
IIB 662 Aug 04 0.034 Apr 01–Nov 23 1.52 0.47 
III 208 Jun 18 0.039 Jan 30–Dec 04 0.63 0.73 
IV 199 Apr 16 0.026 Nov 07–Oct 07 0.26 0.88 
Not done 182 Seasonal variation in breast cancer in Singapore 1187
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The overall health care system in Singapore is ranked very
highly (WHO, 2000) and provides relatively open access to care
although individuals are less likely to self refer during the span
of the New Year (December to February) festivities. In addition, 
the tropical climate is of an essentially unchanging pattern over the
year. For both these reasons a major seasonal component in the
diagnosis of breast cancer (whether induced by climatic changes or
referral) would not be anticipated. Thus the fewer cases in January
and February and the consequential peak of small magnitude in
August reflect self-referral patterns alone and not the presence of
an aetiological determinant. Likewise, the corresponding season-
ality reported in other studies may be enhanced (or obscured) by
local referral characteristics, perhaps leading to a false indication
of an underlying climatic component which might, for example,
influence hormone activity as has been conjectured (Cohen et al,
1983; Mason et al, 1985). 
When seasonality between patients with different characteristics
is compared, our findings are not always consistent with previous
studies. Thus while Kirkham et al (1985) reported peak presenta-
tion for pre-menopausal women was 3 months earlier than for post-
menopausal, they differed by only 4 days in Singapore (Table 1). 
The regression methodology introduced, analogous to that used
routinely in other areas of clinical research, potentially allows a
more detailed investigation of possible seasonal patterns. In this
study, these methods suggested observed differences between
groups might be no more than chance. This will not necessarily be
the case in other geographical locations. 
If a climatic component played a major role in the development
of breast cancer, then one might anticipate some gradient between
studies ranging from northern (and southern) latitudes to the
equator and perhaps similarities between those of common latitude
but differing longitude. One would anticipate little effect at the
equator as we have observed. The findings of certain other studies
may have been distorted by different health care delivery systems
and other confounding variables. Studies reported to date show no
such gradient but the lack of standardization in the identification of
case presentation dates and reporting details make the true position
unclear. To overcome these shortcomings, a coordinated and
prospective study using individual dates of onset, patient specific
and health care delivery details encompassing subjects from many
latitudes and longitudes is required to reveal the extent of a
climatic component, if any, in the aetiology of breast cancer. 
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